Sergei Shevtsov
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
-
- Molecular Biology Techniques and Applications 2
- DNA and Nucleic Acid Chemistry 2
- Advanced biosensing and bioanalysis techniques 1
- Signaling Pathways in Disease 1
- Surgery 3
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- Evgeniy V. Petrotchenko (3 shared papers)Lars C. Pedersen (3 shared papers)Masahiko Negishi (3 shared papers)Risto Kerkelä (2 shared papers)Robert Salomon (2 shared papers)Thomas Force (2 shared papers)Richard D. Patten (2 shared papers)Joseph Alroy (1 shared paper)
- Journals
- Molecular Genetics and Metabolism (2 papers)Human Mutation (1 paper)Nature Medicine (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesRussiaUnited Kingdom
In The Last Decade
Sergei Shevtsov
11 papers receiving 1.4k citations
Sergei Shevtsov's Hit Papers
Peers
Comparison fields: 5 of 107
- Hematology 333
- Cardiology and Cardiovascular Medicine 428
- Genetics 162
- Pharmacology 113
- Rheumatology 177
Countries citing papers authored by Sergei Shevtsov
This map shows the geographic impact of Sergei Shevtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Shevtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Shevtsov more than expected).
Fields of papers citing papers by Sergei Shevtsov
This network shows the impact of papers produced by Sergei Shevtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Shevtsov. The network helps show where Sergei Shevtsov may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergei Shevtsov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cardiotoxicity of the cancer therapeutic agent imatinib mesylate Hit paper breakdown → | 2006 | 858 |
| 2 | 2001 | 245 | |
| 3 | 2006 | 111 | |
| 4 | 2002 | 92 | |
| 5 | 2021 | 63 | |
| 6 | 2003 | 53 | |
| 7 | 1991 | 30 | |
| 8 | 1998 | 11 | |
| 9 | 2016 | 7 | |
| 10 | 1998 | 7 | |
| 11 | 1998 | 6 |
About Sergei Shevtsov
Sergei Shevtsov is a scholar working on Molecular Biology, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Rheumatology, having authored 11 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Molecular Biology Techniques and Applications (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Signaling Pathways in Disease (1 paper), Effects and risks of endocrine disrupting chemicals (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (333 citations), Cardiology and Cardiovascular Medicine (428 citations), Genetics (162 citations), Pharmacology (113 citations) and Rheumatology (177 citations). Sergei Shevtsov has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Evgeniy V. Petrotchenko, Lars C. Pedersen, Masahiko Negishi, Risto Kerkelä, Robert Salomon, Thomas Force, Richard D. Patten, Joseph Alroy, Cezar Iliescu and Stéphanie Pesant. Their work appears in journals such as Molecular Genetics and Metabolism, Human Mutation, Nature Medicine, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.